slides · global inventory
Name Villain
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 1,296
Current window 811-840
Pages 44
Rows per page 30
Slide function
811-840 of 1,296
154
Includes a direct quote from an unnamed source regarding the company's technicians.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
161
The slide uses a Q&A format to substantiate the claim of reckless off-label usage.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
165
The slide uses a Q&A format to present a negative testimonial/critique of the company's sales tactics.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
195
The slide uses a combination of summary text and a direct pull-quote with highlighted text to emphasize the severity of the claims.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
199
The slide uses a Q&A format to present qualitative evidence of operational failures and reputational damage.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
204
The slide uses direct quotes to frame the subject as a villain/incompetent actor. It is a classic 'expert testimony' attack.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
214
This is a highly aggressive, investigative-style slide typical of short-seller research reports.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
227
This slide serves as a specific accusation or 'villain' critique within a research note.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
228
The slide uses a Q&A format to highlight alleged unethical practices regarding organ safety and corporate pressure.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
231
The slide uses a Q&A format to highlight a breakdown in the standard organ procurement process.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
239
The slide uses direct quotes to build a narrative of negligence and poor surgical technique.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
240
This is part of a series of critical research notes (Part 9).TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
241
The slide uses a quote from Congressman Paul Gosar to substantiate claims of a 'bait and switch' business model.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
246
The slide uses a narrative format to expose operational failures and potential ethical/regulatory concerns regarding TransMedics' high-volume users.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
250
The slide uses strong, emotive language to frame the company's leadership as the primary antagonist.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
251
The slide uses highlighted text to emphasize key grievances (dishonesty, forced bundling, anger).TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
253
The slide uses highlighted text to emphasize key quotes from former executives regarding the CEO's professional conduct.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
254
The slide uses direct quotes from former employees and industry contacts to build a negative narrative around the CEO's personality and professional standing.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
257
The slide uses verbatim interview transcripts to substantiate claims of extortion and unprofessional conduct by specific named executives.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
266
The slide uses direct quotes to characterize the CEO as 'arrogant' and the company's behavior as 'extortion' and 'aggressive'.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
270
The slide uses anecdotal evidence from a 'prominent surgeon' to support a bearish thesis on TransMedics.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
271
The slide uses direct quotes from surgeons to build a narrative of financial unviability and institutional pushback against the product.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
273
The slide uses direct quotes to build a narrative of customer churn and institutional resistance.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
281
This slide serves as a highly critical, accusatory statement against the subject company.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
282
The slide uses a testimonial from a transplant surgeon to support a bearish thesis on the company's market position.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
283
The slide uses direct quotes from KOLs to frame the company's technology as a commoditized, overpriced solution with no clinical advantage over traditional cold storage.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
287
The slide uses highlighted text to emphasize key negative findings regarding the OCS technology's performance metrics.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
288
The slide uses a 'before-after' style comparison between a conceptual timeline and actual competitor hardware.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
289
The slide uses expert quotes to undermine the competitive moat of TransMedics by comparing it to existing, commoditized kidney perfusion technology.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
291
The slide uses direct quotes from a surgeon to undermine the company's value proposition.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit